HWHG(SH:600079) Zheng Quan Zhi Xing·2025-07-02 16:25Summary of Key Points Core Viewpoint - The announcement details a shareholding increase plan by the major shareholder,招商生命科技 (Wuhan) Co., Ltd., reflecting confidence in the future development and long-term investment value of 人福医药集团股份公司 [1][5]. Group 1: Shareholder Information - The main shareholder, 招商生命科技, along with its concerted parties, holds a total of 403,089,608 shares, representing 24.70% of the company's total share capital [2][3]. - 招商生命科技 is identified as the controlling shareholder and has a direct stake of over 5% in the company [2]. Group 2: Share Increase Plan - 招商生命科技 plans to increase its shareholding by a minimum of 1% to a maximum of 2% of the total share capital within six months from the announcement date [1][4]. - The increase will be executed through legal and compliant methods such as centralized bidding and block trading on the stock exchange [4]. - The funding for the share purchase will come from self-owned funds and special loans for shareholding increases [4]. Group 3: Implementation Timeline and Pricing - The implementation period for the share increase plan is set from July 3, 2025, to January 2, 2026 [4]. - The maximum purchase price is capped at 25.53 yuan per share [4]. Group 4: Previous Shareholding Activity - Prior to this announcement, 招商生命科技 had already increased its shareholding by 16,322,215 shares, accounting for 1.00% of the total share capital, between April 30, 2025, and June 11, 2025 [3][4]. Group 5: Compliance and Monitoring - The share increase plan complies with relevant laws and regulations, including the Company Law and Securities Law [5]. - The company will continuously monitor the implementation of the share increase plan and fulfill its information disclosure obligations [5].